Clinical Trial Update: Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial in metastatic non-small cell lung cancer assessing cisplatin, gemcitabine, and bevacizumab; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Non-Small Cell Lung Cancer (NSCLC) | Phase 4 | Status: COMPLETED